$692.6M in total Medicare payments across 9 years
Procedure 81519 (Test for detecting genes associated with breast cancer) received $692.6M in total Medicare payments.
Across 188.3K services, the average Medicare payment was $3.7K per service.
AI-generated analysis based on Medicare payment data.
| Year | Payments | Services | YoY Change |
|---|---|---|---|
| 2015 | $56.1M | 16.8K | — |
| 2016 | $59.6M | 17.9K | +6.3% |
| 2017 | $59.9M | 17.8K | +0.4% |
| 2018 | $76.6M | 20.3K | +28.0% |
| 2019 | $83.2M | 22.0K | +8.6% |
| 2020 | $76.6M | 20.0K | -7.9% |
| 2021 | $92.6M | 24.0K | +20.9% |
| 2022 | $93.2M | 24.5K | +0.7% |
| 2023 | $94.7M | 25.0K | +1.6% |
| # | Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|---|
| 1 | Genomic Health, Inc. | Clinical Laboratory | CA | $94.7M | 25.0K | $3.8K |
| State | Payments | Services | Providers | Avg/Provider |
|---|---|---|---|---|
| CA | $94.7M | 25.0K | 1 | $94.7M |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.